Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
Provider: ValuEngine, Inc.
Provider: Reuters Investment Profile
Provider: Ford Investor Services, Inc.

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Marrone Bio Innovations Inc Announces Pricing Of Initial Public Offering

Thursday, 1 Aug 2013 08:15pm EDT 

Marrone Bio Innovations Inc announced the pricing of initial public offering of 4,750,000 shares of common stock at a price to the public of $12.00 per share. The shares are expected to begin trading on the NASDAQ Global Market on August 2, 2013 under the symbol MBII. Closing of the offering is expected to occur on August 7, 2013, subject to customary closing conditions. In addition, MBI has granted the underwriters an option for a period of 30 days to purchase an additional 712,500 shares of common stock. Jefferies LLC and Piper Jaffray & Co. are acting as joint book-running managers for the offering. Stifel, Nicolaus & Company, Incorporated and Roth Capital Partners, LLC are acting as co-managers for the offering. 

Company Quote

0.14 +4.88%
19 Dec 2014